These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 14758361)

  • 1. Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome.
    Flück CE; Tajima T; Pandey AV; Arlt W; Okuhara K; Verge CF; Jabs EW; Mendonça BB; Fujieda K; Miller WL
    Nat Genet; 2004 Mar; 36(3):228-30. PubMed ID: 14758361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antley-Bixler syndrome or POR deficiency?].
    Tomková M; Marohnic CC; Baxová A; Martásek P
    Cas Lek Cesk; 2008; 147(5):261-5. PubMed ID: 18630181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P450 oxidoreductase deficiency: a new disorder of steroidogenesis.
    Miller WL; Huang N; Pandey AV; Flück CE; Agrawal V
    Ann N Y Acad Sci; 2005 Dec; 1061():100-8. PubMed ID: 16467261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compound heterozygous mutations of cytochrome P450 oxidoreductase gene (POR) in two patients with Antley-Bixler syndrome.
    Adachi M; Tachibana K; Asakura Y; Yamamoto T; Hanaki K; Oka A
    Am J Med Genet A; 2004 Aug; 128A(4):333-9. PubMed ID: 15264278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis.
    Huang N; Pandey AV; Agrawal V; Reardon W; Lapunzina PD; Mowat D; Jabs EW; Van Vliet G; Sack J; Flück CE; Miller WL
    Am J Hum Genet; 2005 May; 76(5):729-49. PubMed ID: 15793702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diminished FAD binding in the Y459H and V492E Antley-Bixler syndrome mutants of human cytochrome P450 reductase.
    Marohnic CC; Panda SP; Martásek P; Masters BS
    J Biol Chem; 2006 Nov; 281(47):35975-82. PubMed ID: 16998238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P450 oxidoreductase deficiency: a disorder of steroidogenesis with multiple clinical manifestations.
    Miller WL
    Sci Signal; 2012 Oct; 5(247):pt11. PubMed ID: 23092891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, structural and functional implications of mutations and polymorphisms in human NADPH P450 oxidoreductase.
    Flück CE; Nicolo C; Pandey AV
    Fundam Clin Pharmacol; 2007 Aug; 21(4):399-410. PubMed ID: 17635179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of human CYP1A2-mediated xenobiotic metabolism by Antley-Bixler syndrome variants of cytochrome P450 oxidoreductase.
    Kranendonk M; Marohnic CC; Panda SP; Duarte MP; Oliveira JS; Masters BS; Rueff J
    Arch Biochem Biophys; 2008 Jul; 475(2):93-9. PubMed ID: 18455494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction in hepatic drug metabolizing CYP3A4 activities caused by P450 oxidoreductase mutations identified in patients with disordered steroid metabolism.
    Flück CE; Mullis PE; Pandey AV
    Biochem Biophys Res Commun; 2010 Oct; 401(1):149-53. PubMed ID: 20849814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P450 Oxidoreductase deficiency: Analysis of mutations and polymorphisms.
    Burkhard FZ; Parween S; Udhane SS; Flück CE; Pandey AV
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):38-50. PubMed ID: 27068427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apparent manifesting heterozygosity in P450 oxidoreductase deficiency and its effect on coexisting 21-hydroxylase deficiency.
    Scott RR; Gomes LG; Huang N; Van Vliet G; Miller WL
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2318-22. PubMed ID: 17389698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical analysis of mutations in P450 oxidoreductase.
    Pandey AV
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1186-91. PubMed ID: 17073782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and biochemical consequences of p450 oxidoreductase deficiency.
    Flück CE; Pandey AV
    Endocr Dev; 2011; 20():63-79. PubMed ID: 21164260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditional deletion of cytochrome p450 reductase in osteoprogenitor cells affects long bone and skull development in mice recapitulating antley-bixler syndrome: role of a redox enzyme in development.
    Panda SP; Guntur AR; Polusani SR; Fajardo RJ; Gakunga PT; Roman LJ; Masters BS
    PLoS One; 2013; 8(9):e75638. PubMed ID: 24086598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Silico Analysis of PORD Mutations on the 3D Structure of P450 Oxidoreductase.
    Nurhafizuddin M; Azizi A; Ming LC; Shafqat N
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linking Antley-Bixler syndrome and congenital adrenal hyperplasia: a novel case of P450 oxidoreductase deficiency.
    Williamson L; Arlt W; Shackleton C; Kelley RI; Braddock SR
    Am J Med Genet A; 2006 Sep; 140A(17):1797-803. PubMed ID: 16906539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P450 oxidoreductase deficiency: a new disorder of steroidogenesis affecting all microsomal P450 enzymes.
    Pandey AV; Flück CE; Huang N; Tajima T; Fujieda K; Miller WL
    Endocr Res; 2004 Nov; 30(4):881-8. PubMed ID: 15666840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P450 oxidoreductase deficiency - a new form of congenital adrenal hyperplasia.
    Flück CE; Pandey AV; Huang N; Agrawal V; Miller WL
    Endocr Dev; 2008; 13():67-81. PubMed ID: 18493134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 46,XX DSD and Antley-Bixler syndrome due to novel mutations in the cytochrome P450 oxidoreductase gene.
    Guaragna-Filho G; Castro CC; Carvalho RR; Coeli FB; Ferraz LF; Petroli RJ; Mello MP; Sewaybricker LE; Lemos-Marini SH; D'Souza-Li LF; Miranda ML; Maciel-Guerra AT; Guerra-Junior G
    Arq Bras Endocrinol Metabol; 2012 Nov; 56(8):578-85. PubMed ID: 23295302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.